245 related articles for article (PubMed ID: 17663146)
1. [Generation of mice with glial cell dysfunction].
Tanaka K; Lee HU; Ikenaka K
Brain Nerve; 2007 Jul; 59(7):747-53. PubMed ID: 17663146
[TBL] [Abstract][Full Text] [Related]
2. Murine model of Alexander disease: analysis of GFAP aggregate formation and its pathological significance.
Tanaka KF; Takebayashi H; Yamazaki Y; Ono K; Naruse M; Iwasato T; Itohara S; Kato H; Ikenaka K
Glia; 2007 Apr; 55(6):617-31. PubMed ID: 17299771
[TBL] [Abstract][Full Text] [Related]
3. GFAP aggregates in the cochlear nerve increase the noise vulnerability of sensory cells in the organ of Corti in the murine model of Alexander disease.
Masuda M; Tanaka KF; Kanzaki S; Wakabayashi K; Oishi N; Suzuki T; Ikenaka K; Ogawa K
Neurosci Res; 2008 Sep; 62(1):15-24. PubMed ID: 18602179
[TBL] [Abstract][Full Text] [Related]
4. Gene expression analysis in mice with elevated glial fibrillary acidic protein and Rosenthal fibers reveals a stress response followed by glial activation and neuronal dysfunction.
Hagemann TL; Gaeta SA; Smith MA; Johnson DA; Johnson JA; Messing A
Hum Mol Genet; 2005 Aug; 14(16):2443-58. PubMed ID: 16014634
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of mutated GFAP aggregates revealed by real-time imaging of an astrocyte model of Alexander disease.
Mignot C; Delarasse C; Escaich S; Della Gaspera B; Noé E; Colucci-Guyon E; Babinet C; Pekny M; Vicart P; Boespflug-Tanguy O; Dautigny A; Rodriguez D; Pham-Dinh D
Exp Cell Res; 2007 Aug; 313(13):2766-79. PubMed ID: 17604020
[TBL] [Abstract][Full Text] [Related]
6. Mild functional effects of a novel GFAP mutant allele identified in a familial case of adult-onset Alexander disease.
Bachetti T; Caroli F; Bocca P; Prigione I; Balbi P; Biancheri R; Filocamo M; Mariotti C; Pareyson D; Ravazzolo R; Ceccherini I
Eur J Hum Genet; 2008 Apr; 16(4):462-70. PubMed ID: 18197187
[TBL] [Abstract][Full Text] [Related]
7. Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model.
Ding H; Shannon P; Lau N; Wu X; Roncari L; Baldwin RL; Takebayashi H; Nagy A; Gutmann DH; Guha A
Cancer Res; 2003 Mar; 63(5):1106-13. PubMed ID: 12615729
[TBL] [Abstract][Full Text] [Related]
8. Alexander disease and megalencephalic leukoencephalopathy with subcortical cysts: leukodystrophies arising from astrocyte dysfunction.
Gorospe JR; Maletkovic J
Ment Retard Dev Disabil Res Rev; 2006; 12(2):113-22. PubMed ID: 16807904
[No Abstract] [Full Text] [Related]
9. Novel deletion mutation in GFAP gene in an infantile form of Alexander disease.
Murakami N; Tsuchiya T; Kanazawa N; Tsujino S; Nagai T
Pediatr Neurol; 2008 Jan; 38(1):50-2. PubMed ID: 18054694
[TBL] [Abstract][Full Text] [Related]
10. The Alexander disease-causing glial fibrillary acidic protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and the association of alpha B-crystallin and HSP27.
Der Perng M; Su M; Wen SF; Li R; Gibbon T; Prescott AR; Brenner M; Quinlan RA
Am J Hum Genet; 2006 Aug; 79(2):197-213. PubMed ID: 16826512
[TBL] [Abstract][Full Text] [Related]
11. Alexander disease-associated glial fibrillary acidic protein mutations in mice induce Rosenthal fiber formation and a white matter stress response.
Hagemann TL; Connor JX; Messing A
J Neurosci; 2006 Oct; 26(43):11162-73. PubMed ID: 17065456
[TBL] [Abstract][Full Text] [Related]
12. In vitro treatments with ceftriaxone promote elimination of mutant glial fibrillary acidic protein and transcription down-regulation.
Bachetti T; Di Zanni E; Balbi P; Bocca P; Prigione I; Deiana GA; Rezzani A; Ceccherini I; Sechi G
Exp Cell Res; 2010 Aug; 316(13):2152-65. PubMed ID: 20471977
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of curcumin on GFAP filament organization and down-regulation of GFAP expression in an in vitro model of Alexander disease.
Bachetti T; Di Zanni E; Balbi P; Ravazzolo R; Sechi G; Ceccherini I
Exp Cell Res; 2012 Sep; 318(15):1844-54. PubMed ID: 22705585
[TBL] [Abstract][Full Text] [Related]
14. The origin of Rosenthal fibers and their contributions to astrocyte pathology in Alexander disease.
Sosunov AA; McKhann GM; Goldman JE
Acta Neuropathol Commun; 2017 Mar; 5(1):27. PubMed ID: 28359321
[TBL] [Abstract][Full Text] [Related]
15. Clinical aspects and pathology of Alexander disease, and morphological and functional alteration of astrocytes induced by GFAP mutation.
Yoshida T; Nakagawa M
Neuropathology; 2012 Aug; 32(4):440-6. PubMed ID: 22118268
[TBL] [Abstract][Full Text] [Related]
16. Fluoro-Jade: new fluorescent marker of Rosenthal fibers.
Tanaka KF; Ochi N; Hayashi T; Ikeda E; Ikenaka K
Neurosci Lett; 2006 Oct; 407(2):127-30. PubMed ID: 16949206
[TBL] [Abstract][Full Text] [Related]
17. Synemin is expressed in reactive astrocytes and Rosenthal fibers in Alexander disease.
Pekny T; Faiz M; Wilhelmsson U; Curtis MA; Matej R; Skalli O; Pekny M
APMIS; 2014 Jan; 122(1):76-80. PubMed ID: 23594359
[TBL] [Abstract][Full Text] [Related]
18. Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease.
Li R; Johnson AB; Salomons G; Goldman JE; Naidu S; Quinlan R; Cree B; Ruyle SZ; Banwell B; D'Hooghe M; Siebert JR; Rolf CM; Cox H; Reddy A; Gutiérrez-Solana LG; Collins A; Weller RO; Messing A; van der Knaap MS; Brenner M
Ann Neurol; 2005 Mar; 57(3):310-26. PubMed ID: 15732097
[TBL] [Abstract][Full Text] [Related]
19. Mice with GFAP-targeted loss of neurofibromin demonstrate increased axonal MET expression with aging.
Su W; Xing R; Guha A; Gutmann DH; Sherman LS
Glia; 2007 May; 55(7):723-33. PubMed ID: 17348023
[TBL] [Abstract][Full Text] [Related]
20. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas.
Ding H; Roncari L; Shannon P; Wu X; Lau N; Karaskova J; Gutmann DH; Squire JA; Nagy A; Guha A
Cancer Res; 2001 May; 61(9):3826-36. PubMed ID: 11325859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
